HS
AGTC

HighVista Strategies’s Applied Genetic Technologies Corporation AGTC Stock Holding History

HighVista Strategies’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,200
Closed -$74K – 136
2020
Q3 		$74K Buy
+15,200
New +$83K 0.05% 99

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighVista Strategies's AGTC Position: Q4 2020 in Review

HighVista Strategies sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2020, closing a stake of 15,200 shares — an estimated $74K sold.

HighVista Strategies first reported a position in AGTC in Q3 2020 and held it in 1 quarter. The position peaked at $74K in Q3 2020. 66 funds tracked by Wall St. Rank hold AGTC as of Q4 2020.

  • HighVista Strategies reported no remaining Applied Genetic Technologies Corporation position as of Q4 2020 after selling out during the quarter.
  • HighVista Strategies sold 15,200 Applied Genetic Technologies Corporation shares in Q4 2020, an estimated $74K.
  • HighVista Strategies first reported a position in Applied Genetic Technologies Corporation in Q3 2020 and held it in 1 quarter.
  • HighVista Strategies's Applied Genetic Technologies Corporation position peaked at $74K in Q3 2020.
  • 66 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2020.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.